BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8801295)

  • 1. OK-432 therapy for lymphangioma in children: why and how does it work?
    Ogita S; Tsuto T; Nakamura K; Deguchi E; Tokiwa K; Iwai N
    J Pediatr Surg; 1996 Apr; 31(4):477-80. PubMed ID: 8801295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional Injection of OK-432 in Cystic Hygroma.
    Hazim M; Moses SS; Tan IP
    Med J Malaysia; 2016 Dec; 71(6):328-330. PubMed ID: 28087956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role of cytokines in OK-432 injection therapy for cystic lymphangioma: an approach to the mechanism.
    Fujino A; Moriya Y; Morikawa Y; Hoshino K; Watanabe T; Shimojima N; Kitajima M
    J Pediatr Surg; 2003 Dec; 38(12):1806-9. PubMed ID: 14666473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of OK-432 sclerotherapy for giant cystic hygroma in a newborn.
    Samuel M; McCarthy L; Boddy SA
    Fetal Diagn Ther; 2000; 15(2):93-6. PubMed ID: 10720873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of a recurrent large cystic hygroma in a child with intracystic injection of OK-432.
    Hase T; Kodama M; Sano H; Mizukuro T; Tachiiri T; Ohta S; Shimada M
    Eur J Pediatr; 1996 May; 155(5):424. PubMed ID: 8741048
    [No Abstract]   [Full Text] [Related]  

  • 6. [A successful case report on intralesional OK-432 therapy for cystic mediastinal lymphangiomas].
    Okubo T; Shimada T; Narita Y; Okushiba T; Douke M; Takahashi T; Okushiba S; Motohara T; Katou H
    Kyobu Geka; 1998 Nov; 51(12):1017-21. PubMed ID: 9838780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of orbital lymphangioma using intralesional injection of OK-432.
    Suzuki Y; Obana A; Gohto Y; Miki T; Otuka H; Inoue Y
    Br J Ophthalmol; 2000 Jun; 84(6):614-7. PubMed ID: 10837387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and mechanism of OK-432 therapy in various neck cystic lesions.
    Ohta N; Fukase S; Watanabe T; Ito T; Aoyagi M
    Acta Otolaryngol; 2010 Nov; 130(11):1287-92. PubMed ID: 20450399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerosing of recurrent lymphangioma using OK-432.
    Mikhail M; Kennedy R; Cramer B; Smith T
    J Pediatr Surg; 1995 Aug; 30(8):1159-60. PubMed ID: 7472972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A variety of orbital lymphangioma treatments: one case treated with orbital decompression therapy and the other case with intralesional injection of OK-432 therapy].
    Oyama T; Eguchi K; Cho H; Abe H
    Nippon Ganka Gakkai Zasshi; 2009 Jul; 113(7):732-40. PubMed ID: 19637816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult cystic hygroma: successful use of OK-432 (Picibanil).
    Woolley SL; Smith DR; Quine S
    J Laryngol Otol; 2008 Nov; 122(11):1260-4. PubMed ID: 18430261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children?
    Hall N; Ade-Ajayi N; Brewis C; Roebuck DJ; Kiely EM; Drake DP; Spitz L; Pierro A
    Surgery; 2003 Mar; 133(3):238-42. PubMed ID: 12660633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y; Torisu M
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OK-432 therapy for cervical lymphangioma.
    Sichel JY; Udassin R; Gozal D; Koplewitz BZ; Dano I; Eliashar R
    Laryngoscope; 2004 Oct; 114(10):1805-9. PubMed ID: 15454776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic lymphangioma and plunging ranula treated by OK-432 therapy: a report of two cases.
    Ikarashi T; Inamura K; Kimura Y
    Acta Otolaryngol Suppl; 1994; 511():196-9. PubMed ID: 8203228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of dermabond for closing lymphatic leakage after resection and OK-432 treatment of a lymphangioma.
    Uchida K; Inoue M; Otake K; Miki C; Kusunoki M
    Plast Reconstr Surg; 2008 Nov; 122(5):156e-157e. PubMed ID: 18971700
    [No Abstract]   [Full Text] [Related]  

  • 17. Intralesional injection of OK-432 for vision-threatening orbital lymphangioma.
    Yoon JS; Choi JB; Kim SJ; Lee SY
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):1031-5. PubMed ID: 17577592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The difficulties and risks of surgical treatment of lymphangiomas in the cervicofacial region.
    Ng JW; Wong MK
    J Pediatr Surg; 1996 Oct; 31(10):1463-4. PubMed ID: 8906692
    [No Abstract]   [Full Text] [Related]  

  • 19. [A revolutionary Japanese method for treatment of lymphangioma].
    Claesson G; Gordon L; Kuylenstierna R
    Lakartidningen; 1998 Apr; 95(18):2074-7. PubMed ID: 9621594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of OK-432 (picibanil) sclerotherapy for benign neck cysts.
    Kim MG; Kim SG; Lee JH; Eun YG; Yeo SG
    Laryngoscope; 2008 Dec; 118(12):2177-81. PubMed ID: 19029851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.